Brussels, 27 Feb 2009 - Solvay Pharmaceuticals announces it has entered into a collaboration agreement with ChemDiv, a global chemistry-driven contract research organization, to provide integrated research services from compound screening up to preclinical development of selected molecules.
Although many pharmaceutical companies nowadays work with so-called ‘Contract Research Organizations’, this partnership is perfectly in line with Solvay Pharmaceuticals’ growth strategy and marks a novel way of cooperating with external partners in the field of early discovery. It is unique in the sense that ChemDiv will provide integrated biology and chemistry services under a risk sharing agreement which includes basic research funding and especially milestones based on delivery of compounds meeting certain defined criteria.
“We are very happy to consolidate a portion of our external research activities that are currently being outsourced to several different contract research organizations as this we believe will shorten development timeline. Moreover we are pleased to have found a partner that shares our business model approach” notes Frédéric Cren, Head of Research at Solvay Pharmaceuticals.
Nikolay Savchuk, President and CEO of ChemDiv comments: “I am extremely proud that we were selected by Solvay Pharmaceuticals for this partnership. I’m convinced that we will be able to contribute positively to Solvay’s pipeline with new and innovative compounds.”
About Solvay Pharmaceuticals
Solvay Pharmaceuticals is a research driven group of companies that constitutes the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology and men’s and women’s health. Its 2008 sales were EUR 2.7 billion and it employs more than 9,000 people worldwide. For more information, visit www.solvaypharmaceuticals.com.
About ChemDiv
ChemDiv, Inc. (CHEMDIV) is a global 500+ people organization headquartered in San Diego, CA, USA with subsidiaries in Russia, business and logistics operations around the world. CHEMDIV is a provider of integrated drug discovery services based on a strong chemistry platform. Drug discovery services offered by CHEMDIV cover the complete range of disciplines needed to bring a project from identification of a biological target (i.e. protein expression, assay development etc.) to clinical drug candidates (ADME/PK, toxicity studies, efficacy models etc.).
Integrated Discovery outSource™ solutions include medicinal and synthetic chemistry, pre-clinical development, screening libraries and global logistics to pharma partners worldwide. Visit www.chemdiv.com for more information.
